Yasir Al-Wakeel
Director/Board Member presso MAXCYTE, INC.
Patrimonio netto: 449 933 $ in data 31/03/2024
Posizioni attive di Yasir Al-Wakeel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MAXCYTE, INC. | Director/Board Member | 15/06/2021 | - |
| Independent Dir/Board Member | 15/06/2021 | - | |
| VICORE PHARMA HOLDING AB | Director/Board Member | 07/05/2024 | - |
Storia della carriera di Yasir Al-Wakeel
Precedenti posizioni note di Yasir Al-Wakeel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KRONOS BIO, INC. | Comptroller/Controller/Auditor | 01/08/2020 | 15/09/2023 |
| Director of Finance/CFO | 01/08/2020 | 15/09/2023 | |
| NEON THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2017 | 01/05/2020 |
| MERRIMACK PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 31/03/2017 | 01/07/2017 |
| Director of Finance/CFO | 04/08/2015 | 01/07/2017 | |
| Treasurer | 31/03/2017 | 01/07/2017 | |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment ManagersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Analyst-Equity | 01/04/2008 | 01/06/2015 |
Formazione di Yasir Al-Wakeel
| University of Oxford | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 4 |
| Svezia | 2 |
Posizioni
| Director of Finance/CFO | 3 |
| Comptroller/Controller/Auditor | 2 |
| Director/Board Member | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| MAXCYTE, INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| KRONOS BIO, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Credit Suisse Securities (Europe) Ltd.
Credit Suisse Securities (Europe) Ltd. Investment ManagersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Finance |
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Yasir Al-Wakeel
- Esperienza
